SENTI-202, a groundbreaking CAR NK-cell therapy, targets relapsed/refractory AML, offering hope for patients with limited ...

The blood cancer multiple myeloma is deadly. This disease is personal for us because one of our best friends and colleagues ...

GENEVA, SWITZERLAND / ACCESS Newswire / June 20, 2025 /RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief or the Company), a biopharmaceutical company committed to delivering ...

The financing round was jointly led by new investor Regeneron Ventures and current investor Deerfield Management.

Sanofi and Regeneron are committed to helping patients in the US who are prescribed Dupixent gain access to the medicine and receive the support they may need with the DUPIXENT MyWay® program. For ...

Regeneron and Sanofi are committed to helping patients in the U.S. who are prescribed Dupixent gain access to the medicine and receive the support they may need with the DUPIXENT MyWay® program. For ...

Cellectar Biosciences, Inc. (Nasdaq: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for ...

McCallany is known for TV roles in Netflix’s “Mindhunter” and FX’s “Lights Out.” He also appeared in popular films like ...